Health/Life Sciences – Page 2 of 54

Comparison of simulated imagery, natural vs. artificial

Elon Musk’s claims about brain implants for artificial vision get a reality check

If Elon Musk’s Neuralink brain-implant venture succeeds in its effort to create next-generation brain implants for artificial vision, the devices… Read More

Allen Institute’s OpenScope team stirs up a brainstorm to study the mind’s mysteries

The Allen Institute’s OpenScope program lets scientists study the weird workings of the brain — for instance, how magic mushrooms work their… Read More

Seattle biotech startup Bonum upgrades offices, expands team in its pursuit of cancer drugs

Bonum Therapeutics is moving into new offices near Seattle’s South Lake Union neighborhood and plans to double its headcount in pursuit… Read More

Wellness startup Viome targets oral health with toothpaste and gel formulated via microbiome data

Viome, the Bellevue, Wash.-based wellness and diagnostics company, is putting its efforts around preventive healthcare and longevity where its mouth… Read More

Aurion Biotech gets FDA approval to speed development of vision restoring treatment

Seattle’s Aurion Biotech announced Wednesday that it received special designations from the U.S. Food and Drug Administration that should speed… Read More

Cyrus Biotech spins out company to expand reach of versatile drug development software

Seattle startup Cyrus Biotechnology is spinning out a business that will expand access to the company’s software technology, with the… Read More

Providence created new gen AI tool in 18 days to speed and improve responses to patient messages

The ability to call your doctor’s office and speak to a live human appears to be a thing of the… Read More

NVIDIA and top VC firms invest in Vilya, a biotech spinout from Seattle’s Institute for Protein Design

Vilya, a biotech startup built off technology developed at the Seattle-based Institute for Protein Design, announced an expanded $71 million… Read More

Illustration: Stylized microchip incorporating the look of a whole-slide pathology image

Microsoft, Providence and UW make use of generative AI for digital cancer diagnosis

Researchers at Microsoft, Providence Health System and the University of Washington say they’ve developed a new artificial intelligence model for… Read More

A-Alpha Bio lands $14.5M from Department of Defense to prep for future biological threats

A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab… Read More

Allen Institute and Seattle Children’s to study inflammatory bowel disorder in search of cure

The Allen Institute for Immunology, a division of the Seattle-based Allen Institute, is teaming with Seattle Children’s Research Institute to… Read More

Seattle startup’s telerobotic ultrasound system brings specialist care to underserved areas

Seattle startup Dopl Technologies has developed a telerobotic ultrasound system intended to bring specialist care to patients in rural areas.… Read More

Gates Foundation’s toilet and sanitation exhibit in Seattle is flush with education and innovation

“Everyone poops,” declares the classic children’s book used by parents, including me, to help their kids understand what is a… Read More

The UW’s Institute for Protein Design keeps boosting startups, fueling AI-powered science

The University of Washington’s Institute for Protein Design is on a hot streak. New studies, companies and spinouts are emerging… Read More

AI is boosting drug discovery and development — and sparking questions about proprietary data

The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business… Read More

In-home health screening startup Reperio raises $14M, inks deal with Uber

Travis Rush grew up in the tiny seaside town of Gold Beach in Southern Oregon. With a population of only… Read More

Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal

Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 billion… Read More

New study for early detection of Alzheimer’s shows promising results

A new test for the early detection of Alzheimer’s Disease — potentially even before symptoms are present — show that… Read More

Biotech giant Genmab to acquire Seattle company ProfoundBio in $1.8B deal

ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be acquired by publicly traded Danish… Read More

AI2 Incubator spinout Modulus sells cell therapy tech assets to Boston’s Ginkgo Bioworks

The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator,… Read More

Inside the new Seattle Hub for Synthetic Biology, which uses DNA to ‘record biology over time’

Researchers opened the doors Monday to the new Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg… Read More

Sonoma Bio celebrates new Seattle waterfront R&D center for autoimmune disease research

Sonoma Biotherapeutics on Monday hosted a ribbon cutting ceremony at its new research and development center and office space on… Read More

Looking for non-dilutive funding? 5 tips for startups seeking small business grants

A good idea, preliminary data, and credentials in the field are all key components of landing a small business grant… Read More

Illustration: Visualization of AI structure translated into biomolecule

Leading researchers join effort to support responsible AI for biomolecular design

More than 100 researchers — including a Nobel laureate — have signed on to a call for the scientific community… Read More

Phase Genomics gets $1.5M grant from Gates Foundation to fight cow burp methane

Seattle biotech startup Phase Genomics is receiving $1.5 million from the Bill & Melinda Gates Foundation to fund research into… Read More

Protein design pioneer David Baker on why sharing code is key to building biotech startups

The Institute for Protein Design at the University of Washington is a startup factory, spinning out companies developing new protein-based… Read More

Transplant organ freezing and rewarming technique wins U. of Washington health innovation challenge

A team working on prolonging the lifespan of transplant organs took home the top prize in the 9th annual Hollomon… Read More

Global health nonprofit PATH moving to new HQ space in Seattle that was once home to Tableau

PATH, the global health nonprofit, is moving to a new headquarters space in Seattle’s Fremont neighborhood after 15 years in… Read More

Healionics lands $5.5M to complete human trial of artificial blood vessel for dialysis patients

Healionics, a Seattle-based medical technology company, raised $5.5 million in new financing aimed at helping the company complete an ongoing… Read More

AstraZeneca completes $1.1B acquisition of Univ. of Washington biotech spinout Icosavax

Biotech giant AstraZeneca has completed its $1.1 billion acquisition of Icosavax, a Seattle-based spinout from the University of Washington’s Institute for… Read More